I"Ð<p>New work from a group of researchers at the Broad Institute of MIT and Harvard unveils the cancer-fighting potential of non-cancer drugs. The article describes how the PRISM profiling method was used to to create viability profiles for over \(4000\) drugs across \(578\) human cancer cell lines. Many non-oncology drugs, including one previously approved for arthritis treatment in canines, displayed unexpected cancer-killing activity.</p>

<p>Read more in <a href="https://www.nature.com/articles/s43018-019-0018-6">Nature Cancer</a>, <a href="https://www.broadinstitute.org/news/dozens-non-oncology-drugs-can-kill-cancer-cells">Broad News</a>, the <a href="https://www.bostonglobe.com/business/2020/01/20/could-drug-for-arthritis-dogs-also-fight-cancer-people/SB1iegRYUVyg5I878AaU3J/story.html">Boston Globe</a>, or <a href="https://www.scientificamerican.com/article/old-drug-new-tricks-existing-medicines-show-promise-in-fighting-cancer/">Scientific American</a>.</p>
:ET